ENTITY
mFlusiva
mFlusiva
PulseAugur coverage of mFlusiva — every cluster mentioning mFlusiva across labs, papers, and developer communities, ranked by signal.
Total · 30d
0
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
RECENT · PAGE 1/1 · 2 TOTAL
-
Moderna's mRNA flu vaccine mFLUSIVA gains FDA approval for adults 50+
Moderna has received FDA approval for its mRNA-based flu vaccine, named mFLUSIVA. This vaccine is now authorized for use in all adults aged 50 and older. The approval followed a review process that was described as a "r…
-
FDA approves Moderna's mRNA flu vaccine after initial review refusal · 2 sources tracked
The U.S. Food and Drug Administration (FDA) has approved Moderna's mRNA-based flu vaccine, mFlusiva (mRNA-1010), for adults aged 50 and over. This approval follows an initial refusal by the FDA to review the application…